Expanding antimicrobial wound care dressing product offering

Expanding antimicrobial wound care dressing product offering

November 4 2013

Mölnlycke Health Care, a world leading manufacturer of single-use wound care and surgical products, has signed a licensing agreement with Covalon Technologies to market and distribute antimicrobial film dressings using the Canadian company's technology. 

The dressings, which will be marketed as Mepitel® Film AM and Mepitel® Film IV AM, are the only antimicrobial clear silicone adhesive film dressings that combine Safetac® technology with chlorhexidine and silver, which provides broad-spectrum antimicrobial activity for up to seven days, killing 99.99% of bacteria that it comes into contact with.

Phil Cooper, President of Mölnlycke Health Care's Wound Care Division, said:

"Adding an antimicrobial film dressing to our product portfolio is the next step in reinforcing our position as a global leader in advanced wound care and part of our commitment to help clinicians in the fight against hospital acquired infections."

Mepitel Film AM and Mepitel Film IV AM will initially be launched during the first quarter of 2014 in North America and in the Middle East, followed by other markets in subsequent months.

Headquartered in Göteborg, Sweden, Mölnlycke Health Care's history dates back to 1849.  The Company operates across North America through its regional headquarters in Norcross, Georgia, Canadian sales office in Ontario and has manufacturing facilities in Wiscasset and Brunswick, Maine. Globally, the company has some 7,400 employees across over 30 countries.